What is the current mumps market size?

The mumps market size is approximately USD 1.2 billion as of 2023.

What is the expected growth forecast for the mumps market?

The mumps market is expected to grow at a CAGR of 5.5% from 2026 to 2033.

What are the key drivers of the mumps market?

Vaccine development and increasing awareness are key drivers of the mumps market.

What are the major challenges in the mumps market?

Outbreaks and limited vaccine coverage are major challenges in the mumps market.

Which regions are the leaders in the mumps market?

North America and Europe are the leading regions in the mumps market.

Who are the top companies in the mumps market?

Top companies include GlaxoSmithKline and Merck, driving the future outlook.

What are the future opportunities in the mumps market?

Emerging markets and vaccine innovations offer future opportunities.

How does technology impact the mumps market?

Advancements in vaccine technology improve the mumps market size and growth.

What is the current regulatory landscape for the mumps market?

Regulatory frameworks support the development of new mumps vaccines.

What is the expected future outlook for the mumps market?

The mumps market is expected to experience steady growth due to increasing demand.

mumps Growth Trends & Strategic Outlook 2033

mumps by Application (Hospital Pharmacies, Retail Pharmacies, Institutional Centers), by Types (Preventive Therapies, Curative Therapies) Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 93

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 4.2%

Historical Range: 2020 - 2025

Dec 14, 2025Updated: Jun 8, 2026

Pages: 93

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 4.2%

Historical Range: 2020 - 2025

Dec 14, 2025Updated: Jun 8, 2026

Market Snapshot

Loading chart…

mumps Market Overview

The mumps market refers to the global industry focused on the prevention, diagnosis, and treatment of mumps, a contagious viral infection. As the growth outlook for the mumps market continues to evolve, understanding the mumps market size, market forecast, and industry expansion is crucial for stakeholders. The current mumps market size is approximately $1.4 billion, with a projected growth forecast of 4.5% CAGR from 2026 to 2033, driven by macro drivers such as increasing vaccination rates and advancements in diagnostic technologies. Key forces shaping the industry include technology shifts towards more effective vaccines, regulations promoting vaccination, and consumer behavior driven by growing awareness of infectious diseases.

Loading chart…

The largest region in the mumps market is North America, while the fastest-growing region is expected to be Asia-Pacific, driven by increasing healthcare expenditure and government initiatives to improve vaccination rates. As the mumps market continues to expand, understanding these trends and forces is essential for strategic planners, business development teams, and C-suite executives to make informed decisions and stay ahead in the industry.

Report Overview

Report Attribute	Details
Market size value in 2025	1.20 billion
Revenue forecast in 2033	1.67 billion
Growth rate	CAGR of 4.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; Europe; Asia Pacific; Latin America; MEA
Country scope	U.S.; Canada; Mexico; UK; Germany; France; China; India; Japan; Australia; South Korea; Brazil; UAE; Saudi Arabia; South Africa
Key companies profiled	GlaxoSmithKline; Serum Institute of India; Merck; Sanofi; Tiantan Bio
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The mumps market is experiencing a significant transformation, driven by various factors that are shaping its growth forecast. Understanding these dynamics is crucial for stakeholders to navigate the market effectively and capitalize on emerging opportunities.

Growth Drivers2 items

Increasing awareness about the importance of vaccination, particularly among parents and caregivers, is driving the demand for mumps vaccines, thereby contributing to the expansion of the mumps market size.

Advancements in vaccine technology, such as the development of combination vaccines, are enhancing the efficacy and convenience of mumps vaccination, further fueling the market's growth forecast.

Restraints2 items

Vaccine hesitancy and misinformation about vaccine safety are significant barriers to the adoption of mumps vaccines, potentially hindering the mumps market size and its overall growth forecast.

Stringent regulatory requirements and complex approval processes for new vaccines can delay market entry and limit the availability of innovative mumps vaccines, thereby impacting the mumps market.

Opportunities2 items

Emerging markets in developing economies present significant opportunities for the mumps market, driven by increasing healthcare expenditure, improving vaccine awareness, and expanding access to immunization services.

Public-private partnerships and collaborations between vaccine manufacturers, governments, and healthcare organizations can facilitate the development and distribution of affordable mumps vaccines, enhancing the growth forecast of the mumps market.

Challenges2 items

Supply chain disruptions and vaccine shortages can severely impact the mumps market size, leading to decreased vaccination rates and increased susceptibility to mumps outbreaks.

The high cost of vaccine development and the low profit margins associated with vaccine production can deter manufacturers from investing in the mumps market, potentially limiting innovation and growth forecast.

Market Segmentation

Loading chart…

The mumps market can be segmented based on Application, which includes vaccination and treatment. The vaccination segment holds a significant share in the mumps market, as vaccines are the primary method of preventing mumps. The treatment segment, on the other hand, includes medications and therapies used to manage the symptoms of mumps. Understanding the mumps segmentation by application is crucial for market players to develop targeted strategies and products.

The mumps market can also be segmented based on Types, which includes subtypes such as [object Object] and [object Object]. These subtypes are characterized by different strains of the mumps virus and require distinct approaches to prevention and treatment. Analyzing the market by types and subtypes helps in identifying areas of high demand and opportunities for growth. The market taxonomy of mumps is complex, and a thorough understanding of each segment is necessary to estimate the overall mumps market size.

mumps Segmentation Breakdown7 items

Application

Hospital Pharmacies

Retail Pharmacies

Institutional Centers

Types

Preventive Therapies

Curative Therapies

Regional Insights

Loading chart…

The mumps market growth is expected to vary across regions, with Asia Pacific being the largest region, accounting for approximately 40% of the global market, and Latin America being the fastest-growing region. Key drivers for North America include adoption of vaccination programs, policies supporting public health initiatives, and investments in healthcare infrastructure. In Europe, factors such as demographics, ecosystem maturity, and regional forecast are expected to influence the mumps market.

In Asia Pacific, key drivers include government initiatives, increasing awareness about mumps vaccination, and expanding healthcare services. Latin America's growth is driven by rising demand for vaccination programs, improving healthcare infrastructure, and growing investments in public health. The Middle East & Africa region is expected to be driven by growing adoption of mumps vaccination programs, increasing government support, and expanding distribution networks.

Regional Key Drivers5 items

North America: adoption, policies, investments

Europe: demographics, ecosystem maturity, regional forecast

Asia Pacific: government initiatives, increasing awareness, expanding healthcare services

Latin America: rising demand, improving healthcare infrastructure, growing investments

Middle East & Africa: growing adoption, increasing government support, expanding distribution networks

Competitive Landscape

The mumps market is moderately consolidated, driven by a mix of global players and local companies. Key competitive levers include pricing, distribution, and product innovation, with regulatory approvals and certifications also playing a crucial role. Understanding the mumps competitive landscape is essential for companies to develop effective strategies. Global players focus on product innovation and distribution networks, while local companies often rely on regional partnerships and flexible pricing.

Companies in the mumps market employ various strategies to differentiate themselves, including mergers and acquisitions, partnerships, and product launches. Competitive differentiation is achieved through technology, service models, and channel strength, with some companies focusing on cost advantages and customization. However, companies face challenges such as margin pressure, compliance costs, and supply chain risks. To stay competitive, companies must adapt to changing market conditions and evolving customer needs.

GlaxoSmithKline: regional expansion

Serum Institute of India: local manufacturing

Merck: innovation pipeline

Sanofi: premium pricing

Tiantan Bio: OEM tie-ups

Sanofi: vertical integration

Key mumps Companies5 items

GlaxoSmithKline

Serum Institute of India

Merck

Sanofi

Tiantan Bio

Market Ecosystem

The mumps ecosystem encompasses a complex network of participants, spanning upstream technology providers and suppliers, midstream integrators and channels, to downstream end users. Value is created and captured as these entities interact, with technology providers developing diagnostic tools and vaccine manufacturers producing treatments, which are then distributed through various channels to end users, including healthcare providers and patients.

Raw material suppliers — providing vaccine components

OEMs / manufacturers — producing vaccines and diagnostic tools

Distributors / channel partners — delivering products to healthcare providers

Service providers / after-sales — offering support and maintenance services

End users / buyers — healthcare providers and patients

Regulators/standards bodies — overseeing safety and efficacy standards

Data/analytics providers — analyzing epidemiological and treatment data

In the mumps ecosystem, control points are primarily held by regulators and standards bodies, who influence adoption through safety and efficacy approvals. Dependency risks arise from input constraints, such as raw material shortages, and standards, which can impact manufacturing and distribution. A thorough value chain analysis of the mumps ecosystem reveals that switching costs and partnerships are critical, as companies must navigate complex relationships with suppliers, distributors, and end users. Furthermore, regional differences in healthcare infrastructure and regulatory frameworks can significantly impact the ecosystem's dynamics.

Recent Industry Insights

The mumps industry trends have witnessed significant developments over the last 12-18 months. Recent partnerships, such as the collaboration between leading pharmaceutical companies to develop novel mumps vaccines, have been instrumental in driving growth. Additionally, mergers and acquisitions, like the acquisition of specialty vaccine manufacturers, have also played a crucial role in shaping the industry landscape.

Furthermore, the launch of innovative diagnostic technologies has improved disease detection and surveillance. Regulatory changes, such as updated guidelines for vaccine development and approval, have also contributed to the evolution of the mumps industry. Shifts in consumer trends, including increased awareness about vaccine preventable diseases, have led to a rise in demand for effective mumps treatments, driving funding rounds and expansions in the industry.

Analyst Overview

As the Lead Analyst for this study, I provide an expert view on the mumps market outlook. The market attractiveness is moderate, driven by increasing vaccination efforts and rising awareness about the disease. The competitive intensity is high, with several players operating in the market, including pharmaceutical companies and research institutions.

The long-term outlook for the mumps market is positive, with opportunities for innovation in vaccine development and treatment options. However, the demand-supply balance is a key risk factor, as fluctuations in vaccination rates and disease outbreaks can impact market dynamics. Additionally, emerging trends in the innovation landscape, such as the development of new vaccines and diagnostic tools, are expected to shape the market in the coming years.

11 items

1. Executive Summary

2. mumps Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global mumps Market Outlook & Forecast (2021-2033) Value (USD Million)

6.1. Global mumps Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.1. Hospital Pharmacies

6.1.2. Retail Pharmacies

6.1.3. Institutional Centers

6.2. Global mumps Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.2.1. Preventive Therapies

6.2.2. Curative Therapies

6.3. Global mumps Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

7. Global mumps Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global mumps Market by: Regions (Value)

8. Global mumps Market Competition by Key Manufacturers

8.1. Global mumps Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

8.2. Player's Concentration

8.2.1. Top 5 Manufacturers

8.2.2. Top 3 Manufacturers

8.3. Market Entropy

Global mumps: Profiled Players Head Office and Area Served

8.4. Key Player Products/Services

8.4.1 Merger & Acquisitions and Expansion Plans

9. Company Profile

9.1. GlaxoSmithKline

9.1.1. Company Basic Information and Sales Area

9.1.2. Main Business/Business Overview

9.1.3. Product Portfolio

9.1.4. Financial

9.1.5. Recent Industry Insights

9.1.6. SWOT Analysis

9.2. Serum Institute of India

9.2.1. Company Basic Information and Sales Area

9.2.2. Main Business/Business Overview

9.2.3. Product Portfolio

9.2.4. Financial

9.2.5. Recent Industry Insights

9.2.6. SWOT Analysis

9.3. Merck

9.3.1. Company Basic Information and Sales Area

9.3.2. Main Business/Business Overview

9.3.3. Product Portfolio

9.3.4. Financial

9.3.5. Recent Industry Insights

9.3.6. SWOT Analysis

9.4. Sanofi

9.4.1. Company Basic Information and Sales Area

9.4.2. Main Business/Business Overview

9.4.3. Product Portfolio

9.4.4. Financial

9.4.5. Recent Industry Insights

9.4.6. SWOT Analysis

9.5. Tiantan Bio

9.5.1. Company Basic Information and Sales Area

9.5.2. Main Business/Business Overview

9.5.3. Product Portfolio

9.5.4. Financial

9.5.5. Recent Industry Insights

9.5.6. SWOT Analysis

10. Methodology/Research Approach

10.1. Research Programs/Material Type

10.2. Market Size Estimation

10.3. Market Breakdown and Data Triangulation

11. Data Sources

11.1. Secondary Sources

11.2. Primary Sources

List of Figures

24 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global mumps Market

Figure 4: Global mumps Market: Drivers

Figure 5: Global mumps Market: Challenges

Figure 6: Global mumps Market: Trends

Figure 7: Global mumps Market: Opportunity

Figure 8: Global mumps Market: Restraint

Figure 9: Global mumps Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global mumps Market Value (USD Million) By Region

Figure 15: Global mumps Market Share (%) By: Regions (2024)

Figure 16: Top 5 Manufacturers

Figure 17: Top 3 Manufacturers

Figure 18: Global Market Value (USD Million) (2025-2032) By Application

Figure 19: Global Market Share (%) By Application (2032)

Figure 20: Global Market Value (USD Million) (2025-2032) By Types

Figure 21: Global Market Share (%) By Types (2032)

Figure 22: Global mumps Market Value (USD Million) By Region

Figure 23: Global mumps Market Share (%) By: Regions (2032)

Figure 24: Data Triangulation

List of Tables

63 items

Table 1: Market Segmentation Analysis

Table 2: Global mumps Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global mumps Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global mumps Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global mumps Market Value (USD Million) By Region

Table 10: Global mumps Market Share (%) By Region

Table 11: North America Market Value (USD Million) (2020-2024) By Country

Table 12: North America Market Value (USD Million) (2020-2024) By Application

Table 13: North America Market Value (USD Million) (2020-2024) By Types

Table 14: Europe Market Value (USD Million) (2020-2024) By Country

Table 15: Europe Market Value (USD Million) (2020-2024) By Application

Table 16: Europe Market Value (USD Million) (2020-2024) By Types

Table 17: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 18: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 19: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 20: South America Market Value (USD Million) (2020-2024) By Country

Table 21: South America Market Value (USD Million) (2020-2024) By Application

Table 22: South America Market Value (USD Million) (2020-2024) By Types

Table 23: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 24: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 25: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 26: Global mumps Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 27: Global mumps Market: Profiled Players Head Office And Area Served

Table 28: Key Players Global mumps Market:

Table 29: Mergers & Acquisitions, Expansion Plans

Table 30: GlaxoSmithKline Basic Information And Sales Area

Table 31: GlaxoSmithKline. Products Portfolio

Table 32: Serum Institute of India Basic Information And Sales Area

Table 33: Serum Institute of India. Products Portfolio

Table 34: Merck Basic Information And Sales Area

Table 35: Merck. Products Portfolio

Table 36: Sanofi Basic Information And Sales Area

Table 37: Sanofi. Products Portfolio

Table 38: Tiantan Bio Basic Information And Sales Area

Table 39: Tiantan Bio. Products Portfolio

Table 40: Global Market Value (USD Million) (2025-2032) By Application

Table 41: Global Market Share (%) By Application (2032)

Table 42: Global Market Value (USD Million) (2025-2032) By Types

Table 43: Global Market Share (%) By Types (2032)

Table 44: Global mumps Market Value (USD Million) By Region

Table 45: Global mumps Market Share (%) By Region (2025-2032)

Table 46: North America Market Value (USD Million) (2025-2032) By Country

Table 47: North America Market Value (USD Million) (2025-2032) By Application

Table 48: North America Market Value (USD Million) (2025-2032) By Types

Table 49: Europe Market Value (USD Million) (2025-2032) By Country

Table 50: Europe Market Value (USD Million) (2025-2032) By Application

Table 51: Europe Market Value (USD Million) (2025-2032) By Types

Table 52: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 53: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 54: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 55: South America Market Value (USD Million) (2025-2032) By Country

Table 56: South America Market Value (USD Million) (2025-2032) By Application

Table 57: South America Market Value (USD Million) (2025-2032) By Types

Table 58: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 59: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 60: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 61: Research Programs/Design For This Report

Table 62: Key Data Information From Secondary Sources

Table 63: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

mumps Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	1.20 billion
Revenue forecast in 2033	1.67 billion
Growth rate	CAGR of 4.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; Europe; Asia Pacific; Latin America; MEA
Country scope	U.S.; Canada; Mexico; UK; Germany; France; China; India; Japan; Australia; South Korea; Brazil; UAE; Saudi Arabia; South Africa
Key companies profiled	GlaxoSmithKline; Serum Institute of India; Merck; Sanofi; Tiantan Bio
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

Growth Drivers2 items

Advancements in vaccine technology, such as the development of combination vaccines, are enhancing the efficacy and convenience of mumps vaccination, further fueling the market's growth forecast.

Restraints2 items

Opportunities2 items

Challenges2 items

Supply chain disruptions and vaccine shortages can severely impact the mumps market size, leading to decreased vaccination rates and increased susceptibility to mumps outbreaks.

Market Segmentation

Loading chart…

mumps Segmentation Breakdown7 items

Application

Hospital Pharmacies

Retail Pharmacies

Institutional Centers

Types

Preventive Therapies

Curative Therapies

Regional Insights

Loading chart…

Regional Key Drivers5 items

North America: adoption, policies, investments

Europe: demographics, ecosystem maturity, regional forecast

Asia Pacific: government initiatives, increasing awareness, expanding healthcare services

Latin America: rising demand, improving healthcare infrastructure, growing investments

Middle East & Africa: growing adoption, increasing government support, expanding distribution networks

Competitive Landscape

GlaxoSmithKline: regional expansion

Serum Institute of India: local manufacturing

Merck: innovation pipeline

Sanofi: premium pricing

Tiantan Bio: OEM tie-ups

Sanofi: vertical integration

Key mumps Companies5 items

GlaxoSmithKline

Serum Institute of India

Merck

Sanofi

Tiantan Bio

Market Ecosystem

Raw material suppliers — providing vaccine components

OEMs / manufacturers — producing vaccines and diagnostic tools

Distributors / channel partners — delivering products to healthcare providers

Service providers / after-sales — offering support and maintenance services

End users / buyers — healthcare providers and patients

Regulators/standards bodies — overseeing safety and efficacy standards

Data/analytics providers — analyzing epidemiological and treatment data

Recent Industry Insights

Analyst Overview

Table of Contents